A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective-Reference-Cited by-同舟云学术

A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective

Published:2022-02 Issue:2 Volume:41 Page:174-186
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Lim Hoong Sern^ORCID,Shaw Steven,Carter Alexander W.^ORCID,Jayawardana Sahan^ORCID,Mossialos Elias,Mehra Mandeep R.^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference56 articles.

1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2. NICE. Chronic heart failure in adults: diagnosis and management. 2021. Accessed December 10, 2021. https://www.nice.org.uk/guidance/ng106

3. Acute Heart Failure: Diagnosis and Management,2014

4. House of Commons. Quality of life for patients with heart failure;Rough;Number CDP,2021

5. NHS Digital. Hospital admitted patient care activity, 2016-17. 2021. Accessed December 10, 2021. https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity/2016-17

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison of quality-adjusted life years in older adults after heart transplantation versus long-term mechanical support: Findings from the SUSTAIN-IT study;The Journal of Heart and Lung Transplantation;2024-09

2. “Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World”;The Journal of Heart and Lung Transplantation;2024-06

3. Left ventricular assist device and transcatheter edge-to-edge mitral valve repair in advanced heart failure: allies or enemies?;Frontiers in Cardiovascular Medicine;2024-01-26

4. Cost-effectiveness analysis of HeartMate3 system in patients with severe chronic heart failure and reduced left ventricular ejection fraction;Medical Technologies. Assessment and Choice;2024

5. The transformative potential of left ventricular assist devices in advanced heart failure: no more a therapeutic orphan;European Heart Journal;2023-12-11